Allergy Asthma Immunol Res.  2016 Jul;8(4):279-281. 10.4168/aair.2016.8.4.279.

Is Montelukast Benefical in Children With Atopic Dermatitis?

• Lee AY

• KMID: 2165910
• DOI: http://doi.org/10.4168/aair.2016.8.4.279

Abstract

No abstract available.

MeSH Terms

Child*
Dermatitis, Atopic*
Humans

Reference

1. Roekevisch E, Spuls PI, Kuester D, Limpens J, Schmitt J. Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review. J Allergy Clin Immunol. 2014; 133:429–438.

2. Elias PM, Steinhoff M. "Outside-to-inside" (and now back to "outside") pathogenic mechanisms in atopic dermatitis. J Invest Dermatol. 2008; 128:1067–1070.

3. Boguniewicz M, Leung DY. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev. 2011; 242:233–246.

4. Murphy RC, Hammarström S, Samuelsson B. Leukotriene C: a slow-reacting substance from murine mastocytoma cells. Proc Natl Acad Sci USA. 1979; 76:4275–4279.

5. Busse WW. Leukotrienes and inflammation. Am J Respir Crit Care Med. 1998; 157:S210–3.

6. Rackal JM, Vender RB. The treatment of atopic dermatitis and other dermatoses with leukotriene antagonists. Skin Therapy Lett. 2004; 9:1–5.

7. Dempsey OJ. Leukotriene receptor antagonist therapy. Postgrad Med J. 2000; 76:767–773.

8. Price D. Tolerability of montelukast. Drugs. 2000; 59:Suppl 1. 35–42.

9. Pei AY, Chan HH, Leung TF. Montelukast in the treatment of children with moderate-to-severe atopic dermatitis: a pilot study. Pediatr Allergy Immunol. 2001; 12:154–158.

10. Ehlayel MS, Bener A, Sabbah A. Montelukast treatment in children with moderately severe atopic dermatitis. Eur Ann Allergy Clin Immunol. 2007; 39:232–236.

11. Jeon YH, Min TK, Yang HJ, Pyun BY. A double-blind, randomized, crossover study to compare the effectiveness of montelukast on atopic dermatitis in Korean children. Allergy Asthma Immunol Res. 2016; 8:305–311.

12. Yanase DJ, David-Bajar K. The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis. J Am Acad Dermatol. 2001; 44:89–93.

13. Nettis E, Pannofino A, Fanelli M, Ferrannini A, Tursi A. Efficacy and tolerability of montelukast as a therapeutic agent for severe atopic dermatitis in adults. Acta Derm Venereol. 2002; 82:297–298.

14. Veien NK, Busch-Sørensen M, Stausbøl-Grøn B. Montelukast treatment of moderate to severe atopic dermatitis in adults: a randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol. 2005; 53:147–149.

15. Rahman ML, Choudhury AM, Islam MM. Effectiveness of montelukast in the treatment of atopic dermatitis. Mymensingh Med J. 2006; 15:85–88.

16. Friedmann PS, Palmer R, Tan E, Ogboli M, Barclay G, Hotchkiss K, et al. A double-blind, placebo-controlled trial of montelukast in adult atopic eczema. Clin Exp Allergy. 2007; 37:1536–1540.